American Portfolios Advisors Soligenix, Inc. Transaction History

American Portfolios Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Mar 22, 2023	BUY	$1.31 - $2.35 $1,624 - $2,914	1,240 New	1,240 $1.9 Million
Q4 2020 Mar 22, 2023	BUY	$1.26 - $2.75 $1,562 - $3,410	1,240 New	1,240 $1.59 Million
Q3 2020 Mar 22, 2023	BUY	$1.7 - $2.61 $2,108 - $3,236	1,240 New	1,240 $2.22 Million
Q1 2020 Mar 24, 2023	BUY	$1.42 - $3.34 $1,760 - $4,141	1,240 New	1,240 $2.08 Million

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $119M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.